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Abstract The micronutrients folate and vitamin B12 are es-
sential for the proper development of the central nervous sys-
tem, and their deficiency during pregnancy has been associat-
ed with a wide range of disorders. They act as methyl donors
in the one-carbon metabolism which critically influences epi-
genetic mechanisms. In order to depict further underlying
mechanisms, we investigated the role of let-7 and miR-34,
two microRNAs regulated by methylation, on a rat model of
maternal deficiency. In several countries, public health poli-
cies recommend periconceptional supplementation with folic
acid. However, the question about the duration and periodicity
of supplementation remains.We therefore testedmaternal sup-
ply (3 mg/kg/day) during the last third of gestation from em-
bryonic days (E) 13 to 20. Methyl donor deficiency-related
developmental disorders at E20, including cerebellar and in-
terhemispheric suture defects and atrophy of selective cerebral
layers, were associated with increased brain expression (by
2.5-fold) of let-7a and miR-34a, with subsequent downregu-
lation of their regulatory targets such as Trim71 and Notch
signaling partners, respectively. These processes could be re-
versed by siRNA strategy in differentiating neuroprogenitors
lacking folate, with improvement of their morphological char-
acteristics. While folic acid supplementation helped restoring
the levels of let-7a and miR-34a and their downstream targets,
it led to a reduction of structural and functional defects taking
place during the perinatal period. Our data outline the poten-
tial role of let-7 and miR-34 and their related signaling path-
ways in the developmental defects following gestational
methyl donor deficiency and support the likely usefulness of
late folate supplementation in at risk women.
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Introduction
Embryogenesis implies a series of programming processes
involving accurate time-controlled gene activation/silencing
expressions. Numerous studies have shown that epigenetic
regulations such as DNA methylation and histone modifica-
tion play a critical role on genomic programming during em-
bryogenesis and fetal development by regulating cell prolifer-
ation and differentiation [1, 2]. Epigenetic mechanisms also
serve as important interfaces between genes and environmen-
tal cues [3, 4]. In this respect, epigenetic variability appears to
be susceptible to modulation by exogenous factors such as
nutritional components, and early exposure to inappropriate
maternal diet may lead to developmental disorders and in-
creased risk for certain diseases later in life [5, 6].
Among the Bepigenetic dietary compounds^ identified, the
methyl donors folate (vitamin B9) and vitamin B12 are major
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actors in the one-carbon metabolism that plays a key role in
epigenetic regulations, including during development [7, 8].
Indeed, both vitamins are essential for the transfer of one-
carbon units for synthesis of S-adenosylmethionine (SAM),
the universal methyl donor for biological methylations [9],
and thus, their deficiency results in decreased methylation
capacities [9, 10]. Moreover, B vitamins participate to the
regulation of homocysteine concentration. Folate and vitamin
B12 are essential for the development of the central nervous
system, and a reduced status in these compounds has been
associated with various developmental effects, ranging from
brain growth retardation to major congenital disorders such as
neural tube defects (NTDs), including spina bifida and anen-
cephaly [11–14]. The protective effect of folate on the occur-
rence of NTDs has been clearly demonstrated, leading to na-
tional public health policies recommending periconceptional
supplementation with folic acid [15–18]. Owing to the role of
folate in the methylation pathway, it is accepted that disturbed
methylation may significantly account for the relation be-
tween NTDs and folate [19, 20], reinforcing the epigenetic
hypothesis [21, 22].
MicroRNAs (miRNAs) are small noncoding RNAs
that regulate posttranscriptional gene expression. The
presence of specific miRNAs is enriched in the central
nervous system where they influence cell cycling, cell
differentiation, and apoptosis during development
[23–26]. It has been reported that folate deficiency and
DNA hypomethylation can lead to misexpression of
miRNAs which in turn may substantially affect neural
development [27]. Among the subset of miRNAs known
to be regulated by methylation [28], let-7 (lethal 7) and
miR-34 are believed to exert a requisite role at various
steps of cerebral development, while they would influ-
ence the occurrence of NTDs [27, 29].
We recently showed that methyl donor deficiency (fo-
late and B12) during the embryofetal period in the rat
causes overexpression of miR-124, resulting in the loss
of Stat3 signaling and in a substantial impairment of
brain development [14]. In order to identify further
mechanisms underlying the effect of maternal B-vitamin
status on neural tube and brain development, in line with
potential epigenetic dysregulations, we investigated the
participation of let-7 and miR-34 as well as their related
pathways in the consequences of methyl donor deficiency
both in vivo on a validated rat model of maternal defi-
ciency [30, 31] and in vitro in hippocampal progenitors
[32]. In addition, since folate supplementation is classi-
cally prescribed to women until the end of the first tri-
mester of pregnancy in several countries, we aimed to
test whether a later vitamin supply (i.e., during the last
trimester, corresponding to the third week of gestation in
the rat) could exert beneficial effects on progeny brain
outcome.
MATERIALS AND METHODS
Animals and Tissue Collection
In vivo experiments were performed on a validated animal
model of methyl donor deficiency [30, 31]. They were con-
ducted in compliance with the international guidelines for the
care and use of laboratory animals and were approved by the
local University Research Ethics Board. Wistar rats (Charles
River, l’Arbresle, France) were maintained under standard
laboratory conditions, on a 12-h light/dark cycle, with food
and water available ad libitum. One month before mating,
adult females were fed either a standard diet (Maintenance
diet M20, Scientific Animal Food and Engineering,
Villemoisson-sur-Orge, France) or a methyl donor-deficient
(MDD) low-choline diet (119 vs 1780 mg/kg) lacking folate
and vitamin B12 (Special Diet Service, Saint-Gratien,
France). Methionine content (∼0.4 %) was similar in both
diets. In the supplementation protocol, folic acid (the synthetic
form of folate, Sigma-Aldrich, Saint-Quentin Fallavier,
France) diluted in condensed milk was given per OS at the
dose of 3 mg/kg per day in a final volume of 1 mL to dams
from embryonic days (E) 13 to 20. Matched control dams
received the same volume of vehicle (i.e., 1 mL condensed
milk) over the same period. Whatever the maternal diet, fe-
tuses were collected at E9, E13, E16, or E20. They were
euthanized by excess isoflurane, and then weighed and eval-
uated morphologically with the aid of a BX51WI microscope
(Olympus, Rungis, France) coupled to a ProgRes MF cool
camera (Jenoptik, Jena, Germany). For biochemical analyses,
the brains were rapidly harvested and the midbrain was dis-
sected before freezing in liquid nitrogen and stored at −80 °C.
For immunochemistry, brains were immediately fixed in 4 %-
paraformaldehyde (24–48 h) at 4 °C, dehydrated, and includ-
ed in paraffin. Microtome-generated 12-μm sagittal brain sec-
tions were then mounted onto glass slides and stored at ambi-
ent temperature. In addition, blood samples were collected
from dams for subsequent analyses.
Measurement of Maternal Plasma Concentrations
of Homocysteine, Vitamin B12 and Folate and Offspring
Tissue Concentrations of SAM and SAH
Homocysteine concentrations were measured by HPLC
(Waters, St. Quentin, France) coupled with mass spectrometry
(Api 4000 Qtrap; Applied Biosystems, Courtaboeuf, France)
[33]. Vitamin B12 and folate concentrations were measured
by radio-dilution isotope assay (simulTRAC-SNB; ICN
Pha rmaceu t i c a l s , Ve r s a i l l e s , F r ance ) [ 34 ] . S -
adenosylmethionine (SAM) and S-adenosylhomocysteine
(SAH) concentrations were measured in tissue homogenates
using high-performance liquid chromatography adapted from
Delabar et al. [35]. Proteins were precipitated with 0.2N
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HClO4 before injection on the column (Lichrospher, 100 RP-
C18, 5 μm, 250 × 4 mm ID). The mobile phase, consisting of
50 mmol/L sodium phosphate (pH 3.2), 10 mmol/L heptane
sulfonate, and acetonitrile (10–20 % from 0 to 20 min), was
applied at 0.75 mL/min flow rate. Amounts of SAM and SAH
were quantified using a UV detector set at 254 nm.
DNA Methylation
Global DNA methylation was quantified in brain tissues at
E20 by using the Methylamp™ Global DNA Methylation
Quantification Kit (Epigentek, Euromedex, Mundolsheim,
France), as previously described [36]. According to the man-
ufacturer’s instructions, the methylated fraction of DNA can
be recognized by a 5-methylcytosine antibody and quantified
through an ELISA-like reaction. The amount of methylated
DNA is proportional to the OD intensity.
Histopathological Analyses
For basic histopathological investigations, brain sections were
stained with the DNA fluorochrome 4,6-diamidino-2-
phenylindole (Dapi, Sigma-Aldrich) for the measurement of
thickness of specific brain layers.
For skeleton analysis, the procedure adapted from Wallin
et al. [37] involves complete skinning of fresh eviscerated rat
embryos following a 24-h immersion in 95 % ethanol.
Skeletons were stained for 48 h with 1 % Alcian blue dye,
diluted in an ethanol/acetic acid mix, specific for cartilage
staining. Skeletons were then macerated in 2 % KOH until
bones are visible and were stained for 24 h with 0.12 %
Alizarin red dye diluted in KOH, specific for bone staining.
Specimen were finally cleared and hardened in glycerol/
ethanol baths and stored in 87 % glycerol. Detailed observa-
tions and measurements were performed by means of the
Cell® software (Olympus).
Cell Cultures
H19-7/IGF-IR cell line (ATCC# CRL-2526) was conditional-
ly immortalized from embryonic day 17 rat hippocampi with a
temperature-sensitive simian virus 40 (SV40) large tumor an-
tigen [38]. Cells were seeded at a density of 3 × 105 cells per
well in 24-well plates (Falcon, Dutscher, Brumath, France)
precoated with poly-L-lysine in high-glucose Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10 % fetal calf serum, 50 U/mL penicillin, 50 U/mL strepto-
mycin, 2 mM glutamine, and 1 mM sodium pyruvate, as pre-
viously described [32, 39]. For homogeneity, the same lot of
serum was used throughout all experiments. Cells were
allowed to proliferate at the temperature of 33 °C in 95 %
air/5 % CO2. Selection was maintained with 200 μg/mL
G418. Because standard DMEM does not contain vitamin
B12, methyl donor deficiency was induced by using DMEM
lacking vitamin B9 (Invitrogen, Cergy-Pontoise, France).
After 24 h, cells were washed and shifted to the non-
permissive temperature (39 °C) for induction of their differ-
entiation in high-glucose DMEM (with or without B9) con-
taining 1 % fetal calf serum, N2 supplement (Invitrogen),
0.11 mg/mL sodium pyruvate, and 2 mM glutamine.
Immunohistochemistry
In addition to brain sections used for immunohistological
analysis, cells cultured on poly-L-lysine-precoated glass cov-
erslips were washed, fixed with 4 % paraformaldehyde, and
permeabilized with 0.1 % Triton X-100 (Sigma-Aldrich), as
reported by Akchiche et al. [32] and Kerek et al. [14].
Nonspecific binding sites were blocked in phosphate-
buffered saline containing 1 % bovine serum albumin
(BSA), and incubation was performed overnight with an an-
tibody against one of the following proteins: Trim71 (goat
po lyc lona l , 1 / 200 , USBio log i c a l , Eu romedex ,
Souffelweyersheim, France), Dll1 (sheep polyclonal, 1/200,
USBiological), Notch1 (Rabbit monoclonal, 1/200, Cell
Signaling Technology), Hes1 (rabbit monoclonal, 1/200,
Cell Signaling Technology), Mash1 (rabbit polyclonal,
1/200, Abcam), actin (goat polyclonal, 1/200, Santa Cruz
Biotechnology, Clinisciences, Nanterre, France), and NF68
(rabbit polyclonal, 1/300, USBiological). After a washing
step, immunoreactivity was assessed by incubation in the
presence of an appropriate secondary anti-IgG antibody con-
jugated to AlexaFluor for 1 h at 25 °C (1/1000, Life
Technologies, Saint-Aubin, France). Control experiments
were conducted by omitting the primary antibody.
Immunofluorescence visualization, image acquisition (×20
and ×60 magnification), and unbiased cell counts in randomly
selected fields were performed with a BX51WI microscope
(Olympus) coupled to a ProgRes MF cool camera (Jenoptik)
or a confocal microscope (Nikon Instruments, Champigny sur
Marne, France) and analyzed by Cell® software.
Western Blotting
Following protein extraction with RIPA buffer, Western blot
analyses were performed using standard procedure with
chemiluminescence using ECL system (Bio-Rad, Marnes-la-
Coquette, France), as previously detailed [39]. Antibodies
against the following proteins were used: Trim71 (goat poly-
clonal, 1/1000, LSBio, Clinisciences), Dll1 (sheep polyclonal,
1/1000, USBiological), Notch1 (Rabbit monoclonal, 1/1000,
Cell Signaling Technology), Hes1 (rabbit monoclonal,
1/1000, Cell Signaling Technology), and Mash1 (rabbit poly-
clonal, 1/1000, Abcam, Paris, France).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
chicken monoclonal, 1/1000, Millipore, Fontenay-sous-
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Bois , France) was used as an internal s tandard.
Polyvinylidenedifluoride membranes were incubated for
1 h at room temperature with the corresponding horserad-
ish peroxidase-conjugated preadsorbed secondary anti-
body (1/2000, Santa Cruz).
RNA Extraction
Total RNAwas extracted from 0.5 mg of embryonic midbrain
tissues and from H19-7 cells (102 to 107 cells) and using the
mirVana®miRNA Isolation kit (Applied Biosystems, Foster
City, CA, USA) following the manufacturer’s instructions
and as previously described by Kerek et al. [14]. miRNAs
were isolated using a two-step procedure. In the first step,
samples were disrupted in a denaturing lysis buffer and then
subjected to acid-phenol/chloroform extraction. The second
step consisted on purification over glass-fiber filter that im-
mobilizes the RNA which was later eluted using RNase-free
water. According to the manufacturer’s instructions, no en-
richment procedure is needed while isolating miRNA for ex-
pression profiling using miRNA arrays. The concentration
and purity of RNAwere determined at 260/280 nm by using
a nanodrop spectrophotometer (Multiskan GO).
Analysis of Let-7a and miR-34a Expression
TaqMan RT-qPCR Two-step real-time PCR was used to an-
alyze the expression of microRNAs. In the first step, total RNA
was reverse transcribed using miRNA-specific RT primers
(rno-let-7, rno-miR-34, and U6SnoRNA) and a TaqMan®
MicroRNA Reverse Transcription Kit (Applied Biosystems,
Villebon-sur-Yvette, France). miRNA expression was analyzed
using TaqMan microRNA assays (Applied Biosystems), ac-
cording to the instructions of the manufacturer. The RT reaction
was performed in 15μL volume, containing 1μg RNA sample,
3 μL primer, and master mix adjusted to 15 μL/reaction.
Products of RT reaction (1.33 μL) were used in a real-time
PCR reaction, which also included 10 μL of the TaqMan
Universal Master Mix II, and 1 μL TaqMan miRNA assay
containing the sequence-specific primers of either the target
miRNA (let-7: UGAGGUAGUAGGUUGUAUAGUU, miR-
34: UGGCAGUGUCUUAGCUGGUUGU) or the
U6SnoRNA (CACGAATTTGCGTGTCATCCTT) used as an
endogenous control for normalization. Real-time PCR was car-
ried out by means of a Step One Plus Real-Time PCR System
(Applied Biosystems). Incubations were performed in a 96-
well plate at 95 °C for 10 min for enzyme activation, followed
by 40 cycles of PCR: denaturation (95 °C for 15 s) and
annealing/extending (60 °C for 2 min). Data analysis was per-
formed with the software provided by the manufacturer (Step
One Plus).
In Situ Hybridization The in situ detection of let-7a and
miR-34a was performed on paraffin-embedded sections from
normal and methyl donor-deficient brain tissues by locked
nucleic acid (LNA)-oligo in situ hybridization, as previously
described by Kloosterman et al. [40]. Briefly, the slides were
deparaffinized in xylene, rehydrated in decreasing concentra-
tions of ethanol, and treated with proteinase-k for nucleic acid
release. Slides were then redehydrated and prehybridized in
hybridization buffer with 0.5 nm specific probe (LNA-modi-
fied and digoxygenin (DIG)-labeled oligonucleotide, Exiqon,
Copenhagen, Denmark) complementary to let-7a
(AACTATACAACCTACTACCTCA ) or miR-34a
(ACAACCAGCTAAGACACTGCCA). Sections were then
washed in saline sodium citrate buffer, followed by blocking
in Denhardt solution 1× in a humidified chamber. Slides were
then incubated with anti-DIG antibody (1/500, Roche Applied
Science) for 1 h at room temperature, washed in PBS-T, and
then immunoreactivity was assessed in the presence of a
matching secondary antibody conjugated to AlexaFluor
(1/2000, Molecular Probes) for 1 h at room temperature.
Positive controls (snoRNA U6B, Exiqon: CACGAATT
TGCGTGTCATCCTT) were used for each hybridization
experiment.
Small Interfering RNA (siRNA) and Cell Transfection
Let-7a and miR-34a expression in cell cultures was silenced
using small interfering RNA. The siRNA oligonucleotide du-
plexes were purchased from Ambion (Applied Biosystems)
for targeting the rat let-7a (hsa-let-7a-5p) or miR-34a (hsa-
miR-34a-5p) in H19-7 cells. The siRNA sequence is (sense
strand indicated): 5′-UGAGGUAGUAGGUUGUAUAGUU-
3′ for let-7a, 5′-UGGCAGUGUCUUAGCUGGUUGU-3′ for
miR-34a, and mirVana™ miRNA Inhibitor Negative Control
#1 was used as control for evaluation of the effect of the
experimental miRNA inhibition. siRNA duplexes (25 nM fi-
nal concentration for the first transfection then 10 nM for the
second day retransfection) were transfected with lipofecta-
mine RNAiMax (Invitrogen). Three days post-transfection,
cells were harvested for RNA or protein extraction.
MicroRNATargets RT2 Profiler PCR Arrays
Rat microRNA Targets RT2 Profiler PCR Arrays (Qiagen,
Courtaboeuf, France) in a 96-well plate format were used to
monitor the expression of the most relevant experimentally
documented or bioinformatically predicted gene targets for
let-7a and miR-34a. Biological samples were obtained from
the brains of two to three E20 fetuses and were tested in
duplicate in separate plates. Total RNA was purified using
the RNeasyPlus Mini Kit (Qiagen). Following manufacturer’s
instructions, total RNA was reverse transcribed using RT2
First Strand kit. Reaction was performed in the iCylcler
Mol Neurobiol
instrument (Bio-Rad). The reaction includes a gDNA elimi-
nation step. The RT reaction was performed in a 20-μL vol-
ume containing 10 μL of gDNA-free RNA (500 ng RNA,
2 μL gDNA elimination buffer, and RNase-free water) and
10 μL of RT mix (4 μL RT buffer, 1 μL primer and external
control, 2 μL RT enzyme mix, and 3 μL RNase-free water).
Products of RT reaction were mixed with 91μL of RNase-free
water for a final template volume of 111 μL. For PCR reac-
tion, 1350 μL RT2 SYBR Green mastermix and 1248 μL
RNase-free water were added. Twenty-five microliters of
PCR components were added to each well of the 96-well
plate. Real-time PCR was carried out on a Step One Plus
apparatus (Applied Biosystems). Plates were incubated at
95 °C for 10min for enzyme activation, followed by 40 cycles
of PCR: denaturation (95 °C for 15 s) and annealing/extending
(60 °C for 1 min). Data analysis of the transcription of 84
separate genes was performed with the software provided by
the manufacturer (Step One Plus).
Behavioral Evaluation
As a global functional approach, the Bhoming test^ [41] was
performed in the offspring between postnatal days 5 and 16 in
order to evaluate basic learning performances and locomotor
capacities in the different experimental groups. For this pur-
pose, the maternal diets were as described above and main-
tained after delivery until the last testing day.
The abilities of rat pups to successfully return to their
home-cage by using environmental sensitive information
were recorded in a T-maze, as previously described [42]. At
each time point studied, rats performed one trial test consisting
in moving freely in the T-maze area (30 cm in length for each
arm, walls of 10 cm high, and a corridor of 5 cm wide). The
home-cage (without the dam) was positioned at the end of one
arm and a clean cage of the same size was positioned at the
end of the opposite arm. The corridor of the maze was care-
fully washed between each animal. The test was considered
successful when the pup returned directly to his home-cage
without visiting the arm containing the clean cage and without
returning to the starting arm. The time spent in the home area
was recorded. For homogeneity, tests were always performed
between 8:00 and 11:00 a.m.
Statistical Analysis
Data were analyzed with Statview 5 software for Windows
(SAS Institute, Berkley, CA, USA). They were compared by
using one-way analysis of variance (ANOVA) with Fisher’s
test. P value <0.05 was considered to indicate significance.
RESULTS
Gestational Methyl Donor Deficiency Affects
the One-Carbon Metabolism and Methylation Capacities
that Are Improved by Folic Acid Supplementation
As expected, plasma levels of folate and vitamin B12 were
dramatically reduced in gestating females exposed to the de-
ficient diet. Concomitantly, homocysteinemia was significant-
ly augmented (Table 1). Folic acid supplementation restored
folate concentration and significantly reduced hyperhomocys-
teinemia in the deficient group. In brain tissue homogenates
from E20 fetuses, SAM concentration remained unaffected by
the maternal dietary conditions, whereas SAH concentration
was enhanced by exposure to the deficient diet, in good ac-
cordance with previous studies [30, 43]. As a consequence,
the SAM/SAH ratio, an index of methylation capacities, was
reduced in deficient fetuses (Table 2). When the dams re-
ceived folic acid supplementation, SAM/SAH ratio was sig-
nificantly increased in the brains of deficient fetuses as com-
pared to those exposed solely to methyl donor deficiency.
Consistently, global DNA methylation was reduced by
∼50 % in the fetal brain under low methyl donor conditions,
but was normalized following folic acid supplementation
(Table 2).
Methyl Donor Deficiency Is Associated With Various
Developmental Abnormalities and Defective Closure
of the Posterior and Cephalic Parts of the Neural Tube:
Beneficial Effects of Folic Acid Supplementation
Nutritional methyl donor deficiency starting 1 month prior to
mating affected female ability to conceive. Globally, 45.7 %
gave birth to pups (vs 84 % in controls). The number of live
Table 1 Effects of the dietary
regimen on plasma
concentrations of folate,
vitamineB12, and resulting
homocysteinemia in gestating
females
Control-vehicle MDD-vehicle Control + B9 MDD + B9
Plasma folate (nmol/L) 27.9 ± 8.3 4.6 ± 3.3** 37.1 ± 7.3* 27.8 ± 12.9°
Plasma vitamine B12 (pmol/L) 470.0 ± 137.6 208.3 ± 41.9** 400.8 ± 132.4 207.9 ± 44.1**
Plasma homocysteine (μmol/L) 4.2 ± 1.5 19.6 ± 5.4** 4.1 ± 0.8 9.9 ± 1.3**/°°
Blood samples were obtained at the time of collection of fetuses. Data are means ± SD and were obtained from
5 ≤ n ≤ 21 individuals. Statistically significant differences: **P < 0.01, with respective control; °P < 0.05 and
°°P < 0.01, between MDD-vehicle and MDD + B9
MDD methyl donor deficient diet
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fetuses per litter was consistently reduced (6.7 vs 11.2). In
addition to spontaneous abortions, maternal pup-killing be-
havior and cannibalism was more frequently observed in de-
ficient dams, as previously documented for thiamine deficien-
cy [44].
As previously documented in the same animal model [14],
gestational deficiency was associated with global intrauterine
growth retardation, as reflected by a significant reduction of
body weight, body length, and femur length at the stage of
E20 (Fig. 1a–c). This could be corrected at least partly by folic
acid supplementation during the last third week of gestation.
Morphologic abnormalities were detected in ∼20 % of defi-
cient embryos at E9, E13, and E16, but not, or very excep-
tionally, in controls (Fig. 1d). They were still present at E20,
but at a somewhat lower rate (Fig. 1e), presumably due to
spontaneous abortions of the most affected fetuses. In addition
to marked growth retardation, these abnormalities include
syndactyly and related malformations such as atrophied digits,
conjoined fetuses, as well as various signs indicative of spina
bifida, such as Btwisted tail^ (12 %) and open vertebral canal
(Fig. 1f–h), in addition to delayed ossification and fused ver-
tebrae in the lumbosacral region. Following folic acid supple-
mentation, the occurrence of abnormalities was consistently
reduced (Fig. 1e). Whereas twisted tail was not detected in
supplemented E20 fetuses, opening of the vertebral canal
was still present, but to a smaller extent, as illustrated on
Fig. 1h.
While brain weight at E20 was reduced in the same pro-
portions as body weight (about 15 %) following exposure to
methyl donor deficiency, thicknesses of brain layers such as
the hippocampal CA1 pyramidal layer, the granular cell layer
of the dentate gyrus, and the neurogenic subventricular zone
(SVZ) were more dramatically affected (from 25 to 40 %;
Fig. 2a–d). Again, belated supplementation allowed signifi-
cant reduction of these defects. Importantly, deficiency was
associated, at this developmental stage, with delayed closure
of the cephalic parts of the neural tube, as reflected by improp-
er interhemispheric junction and open cerebellar vermis that
could be largely prevented by folic acid supplementation
(Fig. 2e). As illustrated by Fig. 2f, the occurrence of open
cerebellar vermis at E20 varied from 41 % in deficient fetuses
to ∼3 % in controls and supplemented counterparts.
Methyl Donor Deficiency Increases Expression Levels
of Let-7 and miR-34: Reversion by Folic Acid
Supplementation
When studied by TaqMan RT-qPCR, let-7a expression pat-
terns showed a significant increase (by 2.5-fold) in the mid-
brain extracts from E20 deficient fetuses, an effect that was
reversed by folic acid supplementation (Fig. 3a). Let-7 levels
were increased by the same order of magnitude in vitro in
differentiating hippocampal progenitors lacking folate
(Fig. 3b). Similar observations could be made regarding the
expression patterns of miR-34a (Fig. 3c, d). This was con-
firmed by in situ hybridization in various brain areas including
the hippocampus, the cerebral cortex, and the cerebellum
(Supplementary Fig. S1 and S2).
Early Methyl Donor Deficiency Alters the Expression
Pattern of a Wide Range of Genes Influenced by Let-7
and miR-34 and Involved in Various Aspects
of Development
As shown by Figs. 4 and 5, microarray approach revealed that
methyl donor deficiency was associated with an overall de-
creased expression of known or predicted target genes. More
specifically, the average downregulation of let-7a targets was
above 6-fold in brain tissues from deficient fetuses, 95 %
Fig. 1 Effects of methyl donor deficiency and folic acid supplementation
on rat fetus morphometric properties and developmental abnormalities.
a–c General morphometric measurements in control (C), methyl donor
deficient (MDD), supplemented control (C-B9), and supplemented
deficient (MDD-B9) fetuses at embryonic day (E) 20 (10 ≤ n ≤ 81).
Data are reported as means ± standard deviation. Statistically significant
differences between control and MDD rats, **P < 0.01, and between
MDD and supplemented MDD, °°P < 0.01. d, e Occurrence of
developmental abnormalities in control and MDD fetuses at E9, E13,
and E16 stages (15 ≤ n ≤ 38) and following folic acid supplementation
at E20 (37 ≤ n ≤ 64). Statistically significant differences between control
and MDD rats, **P < 0.01, and between MDD and supplemented MDD,
°°P < 0.01. f Illustrations of developmental abnormalities occurring in
methyl donor-deficient rats: growth retardation, conjoined fetuses, and
digit malformations. g Prevalence of Btwisted tail^ in controls, MMD,
and supplemented rats. h Photographs of the vertebral canal (Alcian
blue/Alizarin red staining) in the various experimental groups (square
brackets delineate open canal)
Table 2 Effects of the maternal
dietary regimen on SAM and
SAH brain concentrations and on
DNA global methylation in E20
fetuses
Control-vehicle MDD-vehicle Control + B9 MDD + B9
Brain SAM (nmol/g tissue) 67.42 ± 2.94 65.72 ± 0.83 68.84 ± 0.85 69.34 ± 2.92
Brain SAH (nmol/g tissue) 2.51 ± 0.29 3.31 ± 0.53** 3.12 ± 0.16 3.14 ± 0.59
SAM/SAH ratio 25.45 ± 2.29 17.83 ± 2.11** 21.03 ± 0.88 22.59 ± 3.73°°
DNA methylation (%) 28.59 ± 5.74 13.86 ± 2.63** 27.91 ± 4.80 27.82 ± 7.78°°
Data are means ± SD and were obtained from 6 individuals. Statistically significant differences: *P < 0.05 and
**P < 0.01, with respective control; °P < 0.05 and °°P < 0.01, between MDD-vehicle and MDD + B9
MDD methyl donor deficient diet, SAM S-adenosylmethionine, SAH S-adenosylhomocysteine
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being downregulated by more than 3-fold. Among them, 12
genes were identified to participate to embryonic development
and cell fate (Fig. 4c), while others are involved in cell migra-
tion, cytoskeleton organization, cell cycle, and RNA traffick-
ing, as indicated in supplementary data (Supplementary
Table S1). Folic acid supplementation reduced significantly
the dysregulation of almost all target genes affected.
Regarding miR-34a, the average downregulation of its targets
was ∼5-fold in deficient samples, 96 % being downregulated
by more than 3-fold (Fig. 5a, b). Fifteen genes are related to
embryonic development and cell fate (Fig. 5c). Others are
involved in cell migration, axon guidance, cell cycle, and ve-
sicular trafficking (Supplementary Table S2). Again, folic acid
supplementation was able to ameliorate gene expression.
Methyl Donor Deficiency Affects Protein Expression
Levels of Known Downstream Pathways of Let-7
and miR-34: Reversion by Folic Acid Supplementation
We chose to investigate Trim71, which is a key effector
of the let-7 microRNA pathway, that promotes cell pro-
liferation and inhibits differentiation to control various
developmental processes [45]. Western blot analysis
showed that the expression level of Trim71 in the fetus
midbrain was repressed at E20 following methyl donor
deficiency, whereas it was restored to normal level fol-
lowing folic acid supplementation (Fig. 6a).
The Notch receptor ligand delta-like 1 (dll1) is a target
of miR-34, and during morphogenesis of the central ner-
vous system, differentiation of neural progenitors is
known to be inhibited by hairy and enhancer of split
homolog 1 (Hes1), whereas it is stimulated by mammali-
an achaete-scute complex homolog 1 (Mash1) [46]. We,
therefore, focused our study more specifically on Notch
signaling pathway. Under deficiency conditions, mid-
brain expression levels of dll1, Notch1, and Hes1 were
noticeably reduced, whereas the expression of Mash1
was more elevated (Fig. 7a). When folic acid supplemen-
tation was applied, the expression of the various proteins
in deficient fetuses was similar to controls.
Silencing Let-7a and miR-34a Restores Their Related
Pathways and Contributes to Rescue Cells Exposed
to Folate Deficiency
Let-7 siRNA that repeatedly inhibited the expression of let-7a
by >85 % after quantification by TaqMan RT-qPCR increased
Trim71 levels in both control and folate-deficient H19-7 cells
at 13 h after induction of their differentiation (Fig. 6c). The
detrimental role of increased let-7a in folate-deficient progen-
itors was further supported by cell morphology of differenti-
ating progenitors (Fig. 6d–f). Indeed, folate deficiency was
accompanied at 13 h of differentiation by a strong reduction
of the number and length of neural processes, as previously
documented [32]. The downregulation of let-7a by siRNA led
to a noticeable restoration of these processes. Although the
treatment by let-7 siRNA slightly modified cell characteristics
in control progenitors, reflecting increased branching projec-
tions, both the number of neurites per cell and the axon length,
were significantly augmented in folate-deficient cells treated
by let-7 siRNA as compared with those treated by non-
targeting siRNA (Fig. 6d–f).
Although the use of non-targeting siRNA (Si−) had no
patent effect on the expression of Notch signaling proteins in
differentiating cells, silencing miR-34a increased significantly
the expression of ddl1, Notch1, and Hes1, while protein
amounts of Mash1 were reduced (Fig. 7b). As for let-7,
miR-34 siRNA had beneficial effects on the morphological
characterist ics of deficient cel ls (Fig. 7d, e and
Supplementary Fig. S3).
Methyl Donor Deficiency Impairs Basic Cognitive
Performances in the Homing Test which Are Ameliorated
by Folic Acid Supplementation
In the early postnatal period corresponding to 5–16 days
of age, control rat pups displayed a strong acquisition of
the Bhome^ signals, as shown by a progressive increase
of the time spent in the home area (Fig. 8). This reflects a
learning process of environmental cues. By contrast,
methyl donor-deficient pups did not exhibit such an ac-
quisition, with no measurable time spent in the home
zone at postnatal days 5 and 9, and reduced time at post-
natal day 16. Although maternal folic acid supplementa-
tion had no patent effects in control pups, it significantly
improved the performance of deprived pups who showed
a 2.5-fold increase of the time spent in the home area as
compared to the non-supplemented deficient group
(p < 0.05).
Fig. 2 Brain defects associated with methyl donor deficiency in rat
fetuses: influence of folic acid supplementation. a Brain weight in
control (C), methyl donor-deficient (MDD), supplemented control (C-
B9), and supplemented-deficient (MDD-B9) fetuses at E20
(15 ≤ n ≤ 29). Statistically significant differences between control and
MDD rats, **P < 0.01, and between MDD and supplemented MDD,
°°P < 0.01. b–d Thicknesses of hippocampal CA1 pyramidal cell layer,
granular cell layer of the dentate gyrus (DG), and subventricular zone
(SVZ) at E20 (12 ≤ n ≤ 21). Statistically significant differences between
control andMDD rats, **P < 0.01, and betweenMDD and supplemented
MDD, °°P < 0.01. e Improper interhemispheric junction and cerebellar
vermis closure (delineated by dotted line areas) in MDD rat fetuses at
E20 and beneficial effects of folic acid supplementation (arrows). f
Prevalence of defective closure of the cerebellar vermis in the various
experimental groups. Statistically significant differences between control
and MDD rats, **P < 0.01, and between MDD and supplemented MDD,
°°P < 0.01
Mol Neurobiol
Mol Neurobiol
DISCUSSION
Folate deficiency is known to affect fetal and neonatal brain
development and can result in various functional deficits (see
[47] for recent review). Developmental disorders are mediated
by a wide range of underlying cellular mechanisms associated
with vitamin deficiency. In the present study, we provide the
first evidence that the epigenetic overexpression of let-7a and
miR-34a, along with the disruption of their related pathways,
would be key players in the deleterious effects of early methyl
donor deficiency on the anatomical and functional develop-
ment of the central nervous system. While it cannot fully
prevent early-occurring NTDs such as spina bifida, maternal
supplementation with folic acid during the period correspond-
ing to the last trimester of pregnancy in women appeared to
help preserve a normal development, at least partly through
restoring let-7 and miR-34 normal expression.
In our animal model, maternal exposure to methyl donor
deficiency is associated with various developmental abnor-
malities, such as spontaneous abortion, intrauterine growth
retardation, congenital malformations, and delayed ossifica-
tion. Underdeveloped skeleton has been already reported in
relationship with low-folate status in the periconceptional
period or following low-paternal dietary folate [48]. Also,
there was a high prevalence of apparent NTDs. These include
defective closure of the posterior neural tube as reflected by
Btwisted^ tail and open spinal canal, both signs being sugges-
tive of spina bifida. Such developmental disorders associated
with folate and/or vitamin B12 deficiency have been largely
reported [11, 12, 49]. In addition to a global atrophy of the
brain in deficient pups, we frequently observed improper in-
terhemispheric junction and unclosed cerebellar vermis, sug-
gesting developmental anomalies of the cephalic part of the
neural tube. The embryonic development of NTDs is com-
plex, with diverse mechanisms operating at different levels
of the body axis. Although homocysteine was shown to be
embryotoxic, it did not appear to be directly responsible for
NTDs [50], and the mechanisms underlying the effect of ma-
ternal B vitamin status on neural tube development remain
elusive.
Neurulation, which is conventionally divided into primary
and secondary phases, is a fundamental event of embryogen-
esis that culminates in the formation of the neural tube, the
precursor of the brain and spinal cord, and neural tube closure
is an essential step in the development of the central nervous
system [51]. The neuroepithelium is entirely proliferative
Fig. 3 Effects of methyl donor deficiency on the expression of let-7 and
miR-34: influence of folic acid supplementation. a Expression levels of
let-7 in arbitrary units (AU) in the midbrains of control (C) and deficient
(MDD) rat embryos at E16 and E20, and effects of folic acid (B9)
supplementation. b Expression levels in control (C) and B9-deficient
(MDD) H19-7 hippocampal cells after induction of their differentiation.
c Expression levels of miR-34 in themidbrains of control and deficient rat
embryos, and effects of folic acid supplementation. d Expression levels in
control and B9-deficient H19-7 cells. All data are reported as
means ± S.D. (12 ≤ n ≤ 24). Statistically significant differences between
control and MDD, *P < 0.05 and**P < 0.01, and between MDD and
supplemented MDD, °P < 0.05 and °°P < 0.01
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during neurulation. Cells begin to exit the cell cycle, with the
onset of neuronal differentiation, only after neural tube closure
is complete. Accurate control of proliferation, differentiation,
and apoptosis of neural cells is crucial for proper development
and maturation of the nervous system. This requires the tem-
poral expression of specific gene sets, most of them being
influenced by epigenetic processes [52, 53]. In this respect,
regulation of gene expression by microRNAs is proving to be
essential for the neurogenic process [54]. Under the conditions
of methyl donor deficiency, we observed a disruption of the
expression of let-7a and miR-34a and their related pathways.
Among the microRNAs relevant to vertebrate nervous system
development, the highly conserved let-7a microRNA would
constitute a key regulator of neural cell proliferation and dif-
ferentiation [55] and has been tightly associated with the oc-
currence of NTDs [29]. Depending on the experimental
models used, it was reported that let-7a could act through
various pathways involving the participation of transcription
factors such as Abrupt, Sox2, Tlx, or cell cycle regulators such
as CDK/Cyclin complexes [56, 57], contributing to the overall
effect of let-7 on increasing the number of cells in the G1
phase of the cell cycle. In the present study, we chose to
further investigate the well-established target of let-7,
Trim71 (also called Lin41), which is required for embryonic
development and proper neural tube closure [29, 58].
According to the study by Maller Schulman et al. [29] in the
mouse, Trim71 is necessary for initiation and correct closure
of the neural tube at the midbrain/hindbrain border. Belonging
to the family of Trim-NHL ubiquitin ligases, Trim71 is highly
expressed in undifferentiated cells, such as embryonic stem
cells, but becomes rapidly downregulated upon differentia-
tion, in response to the rise of let-7 levels [59]. It was reported
to cooperate with microRNAs to repress Cdkn1a expression
and promote embryonic cell proliferation [60]. The data avail-
able suggest a role for Trim71 in the maintenance of stem cell
identity and/or inhibition of premature differentiation. In our
experimental models of methyl donor deficiency, we observed
a strong increase in let-7a expression, especially in rat pups at
the E20 stage and in differentiating progenitors, along with
significantly lower levels of Trim71 protein. These results
are consistent with the relatively high prevalence of anomalies
of the cephalic part of the neural tube depicted in E20 rat pups.
Regarding miR-34a, its expression levels were also found to
be significantly higher under methyl donor deficiency.
Described as belonging to a Blate-brain development^ expres-
sion cluster in the mouse [61], miR-34a regulates numerous
target genes involved in cell cycle, apoptosis, differentiation,
and neuron maintenance [62]. More specifically, an increase
in the expression of miR-34a leads to a decrease of dll1, which
mediates its effects by binding to the Notch receptor, causing
Fig. 4 Transcriptional alteration of relevant experimentally documented
or bioinformatically predicted gene targets of let-7a in fetal brain under
methyl donor deficiency: effects of folic acid supplementation. qPCR
analysis was performed by means of Rat microRNA Targets RT2
Profiler PCR Arrays (Qiagen) monitoring 84 specific genes. Biological
samples were obtained from the brains of two to three E20 fetuses for
each condition and were tested in duplicate in separate plates. a Mean
downregulation (± S.D.) in methyl donor-deficient (MDD) and
supplemented-deficient (MDD-B9) fetuses. b Percentage of genes
downregulated by more than 3-fold. c Downregulation of selected
target genes involved in embryonic development and cell fate.
Statistically significant differences between MMD and MDD-B9:
*P < 0.05, **P < 0.01
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its proteolytic cleavage and release of the Notch intracellular
domain [63]. Notch is known to play a role in the developing
central nervous system by inhibiting neuronal differentiation
and maintaining neural precursor cells. Hes1, a major down-
stream target of Notch, suppresses neuronal differentiation by
repressing expression of, among other targets, the activator-
type bHLH gene Mash1 [64]. In the present study, all the
above-mentioned members of the Notch signaling pathway
were dramatically affected by methyl donor deficiency. This
would finally result in decreased cell proliferation and prema-
ture neuronal differentiation [65]. Taken together, our data
therefore suggest that the alterations observed in let-7 and
miR-34 pathways in response to methyl donor deficiency
may participate to a disruption of the proliferation/
differentiation balance, resulting in improper development of
the central nervous system, and influencing the occurrence of
NTDs. As pointed out by Copp et al. [66], premature differ-
entiation in the neuroepithelium might render the neural plate
mechanically inflexible and prevent dorsolateral bending, in-
terfere with the release of neural crest cells or inhibit the ad-
hesion process that is necessary for neural fold fusion.
Furthermore, overexpression of miR-34a has been reported
to alter neurite outgrowth and synaptogenesis, with functional
consequences, in particular at the electrophysiological level
[67]. Such observations are consistent with our previous find-
ings in developing neuroprogenitors showing that folate dep-
rivation markedly affects cell polarity, neurite outgrowth, ve-
sicular transport, and synaptic function and plasticity [32].
Finally, the methyl donor deficiency-associated poorer scores
recorded in the homing test at postnatal days 5–16 are in good
correlation with the observation of persisting atrophy of some
brain cell layers, notably in the hippocampus, in rat pups ex-
posed to the same conditions of B vitamin deficiency as in the
present study [14], suggesting long-lasting functional defects.
Our experimental conditions reduced methyl donor avail-
ability and affected the one-carbon metabolism, and thus,
methylation capacities, as previously documented both in the
rat progeny [30, 43, 68] and in H19-7 neuroprogenitors [32].
Periconceptional/gestational administration of folic acid is
recognized for its beneficial effects, especially for the preven-
tion of NTDs. However, questions remain about the optimal
dose and appropr i a t e pe r iod ic i ty of fo l i c ac id
Fig. 5 Transcriptional alteration of relevant experimentally documented
or bioinformatically predicted gene targets of miR-34a in fetal brain under
methyl donor deficiency: effects of folic acid supplementation. qPCR
analysis was performed by means of Rat microRNA Targets RT2
Profiler PCR Arrays (Qiagen) monitoring 84 specific genes. Biological
samples were obtained from the brains of two to three E20 fetuses for
each condition and were tested in duplicate in separate plates. a Mean
downregulation (± S.D.) in methyl donor-deficient (MDD) and
supplemented-deficient (MDD-B9) fetuses. b Percentage of genes
downregulated by more than 3-fold. c Downregulation of selected target
genes involved in embryonic development and cel l fate .
Statistically significant differences between MMD and MDD-B9:
*P < 0.05, **P < 0.01
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supplementation. The U.S. Public Health Service and CDC
recommend that all women of childbearing age ingest
0.4 mg folic acid daily. WHO guidelines also recommend
0.4 mg per day for all women between 15 and 45 years of
age, whereas women with history of NTD are encouraged to
take 4 mg during the first 3 months of pregnancy. Folate de-
ficiency during late gestation has been shown to decrease
progenitor cell proliferation and increases apoptosis in fetal
mouse brain [69, 70]. In addition, it has been reported that
differences in birth weight and neurocognitive development
related to environmental factors are most likely initiated dur-
ing the second and third trimesters of pregnancy [71]. As a
consequence of our protocol of belated supplementation, met-
abolic features were ameliorated, and we observed a reduction
of structural and functional (homing test) defects taking place
during the peak of brain maturation in the perinatal period.
Most importantly, folic acid supplementation helped restoring
the levels of let-7 and miR-34 and their respective targets.
As recently reviewed by Imbard et al. [22], several
mechanisms have been proposed to account for the role
of folate and vitamin B12 during embryogenesis. They
include decreased oxidative stress and increased nucleo-
tide biosynthesis, facilitating DNA replication. Since
both vitamins are involved in the methylation pathway,
several authors have pointed out that disturbed methyla-
tion and related epigenetic changes could be responsible
for developmental abnormalities and birth defects
[19–21]. This is supported by the deleterious effects of
polymorphisms in genes involved in the methylation
pathway such as methylenetetrahydrofolate reductase
(MTHFR), coding for a key enzyme of folate metabolism
implied in homocysteine remethylation [72, 73], and
Fig. 6 Effects of methyl donor deficiency and folic acid supplementation
on Trim71, a target of let-7. Consequences of silencing let-7a on
differentiating H19-7 cells. a Western blot analyses of Trim71
expression in the midbrain of control (C) and deficient (MDD) E20
fetuses and effect of acid folic (B9) supplementation. Similar findings
were obtained from three other experiments using tissue extracts from
distinct embryonic brains. b Summary of events involved in the
consequences of methyl donor deficiency in the rat brain (see the
BDiscussion^ section). c Expression levels of Trim71 and effects of let-
7 siRNA in control (C) and folate-deficient (MDD) H19-7 cells at 13 h
after induction of differentiation (Si− = non-targeting siRNA, Si+ = let-7-
targeted siRNA). Expression patterns are representative of four separate
series of Western blots. d Average number of cell processes per cell. e
Mean axon length. For d and e: statistically significant difference with the
respective control: *P < 0.05 and **P < 0.01; statistically significant
difference between Si− and Si+: °P < 0.05 (n = 5). f Representative
influence of let-7 siRNA on cell morphology at 13 h after induction of
differentiation. Cells are colabeled with antibodies against actin (green)
and NF68 (red) and their nuclei counterstained by Dapi (blue)
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Fig. 7 Effects of methyl donor deficiency and folic acid supplementation
on Notch signaling proteins, targets of miR-34. Consequences of
silencing miR-34a on differentiating H19-7 cells. a Western blot
analyses of Notch signaling proteins expression in the midbrain
of control (C) and deficient (MDD) E20 fetuses and effect of acid folic
(B9) supplementation. Similar findings were obtained from three other
experiments using tissue extracts from distinct embryonic brains. b
Expression levels of Notch signaling proteins and effects of miR-34
siRNA in control (C) and folate-deficient (MDD) H19-7 cells at 13 h
after induction of differentiation (Si− = non-targeting siRNA, Si+
= miR-34-targeted siRNA). Expression patterns are representative of four
separate series of Western blots. c Summary of events involved in the
consequences of methyl donor deficiency in the rat brain (see the
BDiscussion^ section). d Average number of cell processes per cell. e
Mean axon length. For d and e: statistically significant difference with
the respective control: *P < 0.05 and**P < 0.01; statistically significant
difference between Si− and Si+: °P < 0.05 (n = 5)
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whose activity is affected in our animal model [74].
Interestingly, MTHFR is a predicted target of miR-34a
[27]. An increase in miR-34a would lead to a decrease
in MTHFR expression, reducing methionine amounts to
finally decrease methylation reactions and increase ho-
mocysteine levels.
In conclusion, we showed that methyl donor deficiency
was associated with enhanced expression of let-7a and
miR-34a, with subsequent alterations of their development
regulatory targets such as Trim71 and Notch signaling
partners. The latter data are consistent with the previous
demonstrations that folic acid is able to stimulate Notch
signaling, including Hes1 transcription, and promotes cell
proliferation in neural stem cells [75–77]. Taken together,
the positive impact observed after folic acid supplementa-
tion and following siRNA strategy, along with the associ-
ated normalization of let-7a and miR-34a, strengthen the
potential role of these microRNAs and their related signal-
ing pathways in the developmental defects consecutive to
gestational methyl donor deficiency. By using the micro-
array approach, the identification of new putative target
genes affected in response to methyl donor deficiency via
let-7 and miR-34 warrants further investigations. Finally,
our data support late gestational folate supplementation in
at risk women, as we report for the first time its beneficial
role on brain maturation in the progeny. According to the
Bfetal programming^ hypothesis, gestational exposure to
appropriate concentrations of methyl donors may help re-
duce the susceptibility to certain diseases in adulthood by
favorably influencing epigenetic profiles [78].
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